E-BEARS: Electrical & Computer - Baylor Engineering & Research Seminars

Orhan Kemal Öz, M.D., Ph.D.
Professor, Radiology and Biomedical Engineering, Division Chief, Nuclear Medicine
The University of Texas Southwestern Medical Center

Presents

Clinical Molecular Imaging - An Overview of the Current State and Opportunities for Collaborations to Make it Better

Date: Thursday, April 11, 2024

Time: 9:00 AM – 10:00 AM

Location: Rogers 210

Abstract:

This presentation provides a comprehensive review of clinical molecular imaging, specifically Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) modalities, illustrated through various case studies. We will explore the standard imaging workflow and the associated challenges, drawing upon examples from existing literature and ongoing research at the University of Texas Southwestern Medical Center to address these obstacles. The discussion will highlight potential collaboration avenues for computer scientists and A.I. specialists to contribute to healthcare, particularly within this workflow. Special attention will be given to the aspects of image quality and the interpretative challenges faced by radiologists and nuclear medicine physicians in clinical examinations.

Short Bio:

Dr. Orhan Kemal Öz is a Professor at the Department of Radiology and Biomedical Engineering and at the Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, where he also serves as the Division Chief of Nuclear Medicine. With a B.S. from Morehouse College and an M.D. and Ph.D. in Biophysics from Stanford University, Dr. Oz has established himself as a leader in Nuclear Radiology. His postdoctoral training in Molecular Biology and Radiology, coupled with a fellowship in PET Imaging from UCLA, has positioned him at the forefront of diagnostic radiology and nuclear medicine. Dr. Oz’s 20+ years of experience in Nuclear Radiology, particularly in dual-modality imaging, is complemented by his broad science knowledge and clinical expertise in the development and application of novel radiotracers and imaging methods. His research, which focuses on the molecular profiling of diseases such as infections, cancer, and endocrine disorders, has contributed to the integration of quantitative imaging biomarkers into clinical practice. His current work in molecular imaging of kidney cancer, particularly through immunoPET imaging, highlights his commitment to advancing medical science. As a past Chair of the National Institute of Health (NIH)’s Contrast and Molecular Imaging Probe review panel and a recipient of numerous honors, including the Robert W. Parkey, M.D., Distinguished Professorship in Radiology, Dr. Oz’s contributions to science are widely recognized.